We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$8.27B
AUM Growth
+$555M
Cap. Flow
+$466M
Cap. Flow %
5.63%
Top 10 Hldgs %
27.66%
Holding
409
New
6
Increased
189
Reduced
152
Closed
18

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$98.2M
2
AMGN icon
Amgen
AMGN
+$71.4M
3
TXN icon
Texas Instruments
TXN
+$39.2M
4
MMM icon
3M
MMM
+$22M
5
TFC icon
Truist Financial
TFC
+$19.2M

Top Sells

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$33M
2
KMB icon
Kimberly-Clark
KMB
+$32.7M
3
O icon
Realty Income
O
+$26.9M
4
JCI icon
Johnson Controls International
JCI
+$20.1M
5
ABBV icon
AbbVie
ABBV
+$19.7M

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Technology 16.64%
3 Consumer Staples 15.19%
4 Financials 12.88%
5 Industrials 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
126
Clorox
CLX
$12.7B
$3.66M 0.04%
29,216
-733
-2% -$96K
THO icon
127
Thor Industries
THO
$4.14B
$3.65M 0.04%
43,052
-6,560
-13% -$510K
WAB icon
128
Wabtec
WAB
$50.2B
$3.56M 0.04%
43,617
+5,896
+16% +$433K
COHR icon
129
Coherent
COHR
$65.5B
$3.47M 0.04%
142,557
+2,275
+2% +$48.1K
HUBB icon
130
Hubbell
HUBB
$27.2B
$3.45M 0.04%
32,040
EFA icon
131
iShares MSCI EAFE ETF
EFA
$79.5B
$3.31M 0.04%
55,891
-1,045
-2% -$60.6K
PSX icon
132
Phillips 66
PSX
$80.5B
$3.22M 0.04%
39,983
-714
-2% -$55.5K
CL icon
133
Colgate-Palmolive
CL
$74.4B
$3.18M 0.04%
42,915
-25,288
-37% -$1.87M
WST icon
134
West Pharmaceutical
WST
$24.6B
$3.14M 0.04%
42,090
+2,386
+6% +$189K
DUK icon
135
Duke Energy
DUK
$96B
$3.12M 0.04%
38,956
-173
-0.4% -$14.3K
IBM icon
136
IBM
IBM
$225B
$2.9M 0.04%
19,060
-635
-3% -$96.4K
HMN icon
137
Horace Mann Educators
HMN
$2.1B
$2.85M 0.03%
77,920
-12,675
-14% -$449K
DEO icon
138
Diageo
DEO
$49.1B
$2.85M 0.03%
24,588
ISRG icon
139
Intuitive Surgical
ISRG
$132B
$2.8M 0.03%
34,812
+45
+0.1% +$3.45K
SIMO icon
140
Silicon Motion
SIMO
$8.48B
$2.8M 0.03%
54,067
+3,280
+6% +$171K
TXRH icon
141
Texas Roadhouse
TXRH
$13.8B
$2.79M 0.03%
71,421
+7,147
+11% +$320K
VFC icon
142
VF Corp
VFC
$6.03B
$2.77M 0.03%
52,417
-2,087
-4% -$121K
MEI icon
143
Methode Electronics
MEI
$581M
$2.65M 0.03%
75,881
+4,860
+7% +$171K
HDV
144
iShares Core High Dividend ETF
HDV
$14.8B
$2.64M 0.03%
162,350
-14,360
-8% -$236K
SO icon
145
Southern Company
SO
$107B
$2.63M 0.03%
51,336
-32
-0.1% -$1.69K
GS icon
146
Goldman Sachs
GS
$317B
$2.59M 0.03%
16,055
-2,031
-11% -$330K
V icon
147
Visa
V
$688B
$2.57M 0.03%
31,086
-298
-0.9% -$23.9K
CBU icon
148
Community Bank
CBU
$3.49B
$2.56M 0.03%
53,298
+8,600
+19% +$388K
RDS.A
149
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.55M 0.03%
52,788
-927
-2% -$45.3K
AVNT icon
150
Avient
AVNT
$3.47B
$2.54M 0.03%
75,277
+13,450
+22% +$466K

Similar funds

Bahl & Gaynor's Q3 2016 Portfolio in Review

As of Q3 2016, Bahl & Gaynor held 409 positions worth $8.27B, up 7.2% from $7.71B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor deployed $466M of net new capital in Q3 2016, opening 6 new positions and adding to 189 existing holdings. Its largest new stake was Dollar General: 145,451 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was J.M. Smucker, an estimated $33M trimmed.

  • Bahl & Gaynor's largest Q3 2016 buy was Dollar General: 145,451 shares worth $10.2M.
  • Bahl & Gaynor added most to Abbott in Q3 2016, an estimated $98.2M increase.
  • Bahl & Gaynor's biggest Q3 2016 reduction was J.M. Smucker, cutting an estimated $33M.
  • Bahl & Gaynor fully exited Ross Stores in Q3 2016, selling an estimated $864K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $8.27B portfolio in Q3 2016.
  • Bahl & Gaynor opened 6 new positions and closed 18 in Q3 2016.
  • Bahl & Gaynor's portfolio value rose 7.2% quarter-over-quarter to $8.27B.

Based on Bahl & Gaynor's 13F filing for Q3 2016, filed 7 Nov 2016.